Last updated
Revenue
R&D Expenses
Operating CF
Total Assets
Total Liabilities
Equity
Shares Out.
D/E Ratio
Dilution Watch
Financials
52W LOW $23.7052W HIGH $32.24
Volume
836.27 K
Value Traded
26.98 M
Short % Float
0.27%
-4.74%Week
-5.42%1 Month
-15.06%3 Month
-8.79%6 Month
-49.18%5 Year
+722.04%All Time
Cash Data
- Monthly Burn
- Burn Trend
- Dilution Risk
- SEC Filing
Key Stats
Market Cap
23.51 B
EPS (TTM)
1.18
P/E Ratio
20.23
Ent. Value
32.18 B
Total Shares
982.88 M
Float Shares
977.31 M
Insiders
0.01%
Institutions
5.27%
Upcoming Catalysts
FDA decisions, readouts and PDUFA dates · scored by probability of approval
| Catalyst | Drug / Treatment | Stage | Prob. of Approval | Description | Drug Type | Therapeutic Area | Source |
|---|---|---|---|---|---|---|---|
PDUFA 2026 | Example Drug Treatment for example condition requiring FDA review | Phase 3 | Small Molecule | Oncology | - |
PoA blends historical approval base rates, trial design score and FDA review track record.
PHG Catalyst Timeline
Dated clinical, regulatory and corporate events for Koninklijke Philips N.V. NY Registry Shares
Past FDA Catalysts and PDUFA Decisions
How PHG actually traded into and out of each decision
| Date | Drug | Catalyst | Stage | Reaction | Event Move % | Best Trade % |
|---|---|---|---|---|---|---|
| - | Example Drug | Phase 3 data readout | Phase 3 |
Reaction: 30 trading days around the event · Event Move: close to close on decision day · Best Trade: peak run-up from entry 10 days before the decision
Drug Pipeline Intelligence
F17 / 100
Pipeline Score
$0M
Pipeline Value
Not rated
Valuation Signal
1
Drugs Scored
-
rNPV / MCap
Top 97%
Mid Cap(rank 638 of 658)
Percentile Rank
Koninklijke Philips N.V. NY Registry Shares has significant pipeline risk (17/100), with 1 assets in development.
| Drug | Indication | Phase | PTRS | rNPV | Status | Enroll | Velocity | Design | Est. Completion | ML Signal | Last Change |
|---|
Clinical Trial Results
Readouts, endpoints and source filings for every PHG program
Inside Trades
| Insider | Side | Shares | Price | Value | Date |
|---|---|---|---|---|---|
| John SmithCEO | Buy | 50,000 150,000 held | $45.50 | 01/10/2026 |
Hedge Fund 13F Activity
Hedge Funds invested in PHG
| Fund | % of Portfolio | Current MV | Shares Owned | Activity |
|---|---|---|---|---|
| SOLEUS CAPITAL MANAGEMENT, L.P. | 0.6 % | 3.48 M | 61.05 K |
PHG Institutional Ownership Trends
Options Data
Option Volume
Open Interest
Call OI
Put OI
Put-Call Ratio
OI 30-day avg
Today vs avg
Option Volume
Call Vol
Put Vol
Put-Call Ratio
Vol 30-day avg
Today vs avg
Option Chain Statistics
| Expiry | Call Vol | Put Vol | Vol P/C | Call OI | Put OI | OI P/C | IV Call | IV Call OI-Wtd | IV Call Vol-Wtd | IV Put | IV Put OI-Wtd | IV Put Vol-Wtd |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-11-20 | ||||||||||||
Real-Time Option Chain
| Calls | Strike | Puts | ||||
|---|---|---|---|---|---|---|
| Last | Vol | OI | Last | Vol | OI | |
| No data available | ||||||
Calls vs Puts by Expiry
CallsPutsLog scale
Competitive positioning
How PHG ranks across every disease it competes in
Competitive Position is a premium feature
See how PHG ranks against every competitor across each disease it develops in: phase, best drug, trials and likelihood of approval.
Start free trialPHG News
PHG▲ +0.5%today
Philips Sonicare Next-Generation DiamondClean 9900 Prestige Is Now Available On Amazon; The Brand’s Most Advanced, Intelligent Toothbrush That Gives Users Real-Time Guidance Alongside Signature Brushing Performance
Royal Philips has launched the Philips Sonicare Next-Generation DiamondClean 9900 Prestige, now available on Amazon. This toothbrush features advanced technology, including real-time spatial guidance and an on-device mouth map to improve brushing performance. As the leading power toothbrush brand recommended by dentists in the U.S., Philips continues to innovate in oral care.
Read more →PHGPhilips OneBlade and Red Bull take self-expression to new heights in Cappadocia, Turkey
Philips OneBlade partnered with Red Bull athlete Marco Waltenspiel to execute a world-first wingsuit hot-air balloon slalom in Cappadocia, Turkey. The event showcased Waltenspiel's unique style and the spirit of self-expression. With speeds reaching 200 km/h, the collaboration emphasizes individuality and the freedom to shape one's look. Philips aims to inspire others to challenge conventions.
Read more →PHGPhilips Launches Revolutionary Lumea® IPL 9900 Pro: the First At-Home Intense Pulsed Light (IPL) Hair Removal Device With Real-Time Audio Guidance That Talks to You During Treatment
Philips has launched the Lumea IPL 9900 Pro, an at-home hair removal device featuring real-time audio guidance. This innovative product aims to enhance user confidence and personalize the hair removal experience. As the leading IPL brand, Philips leverages 25 years of research to ensure effective treatment.
Read more →PHGRiassunto: Philips e Imricor lanciano una soluzione per laboratorio di risonanza magnetica interventistica cardiaca, ampliando la loro collaborazione di lunga data
Philips and Imricor have announced a new interventional MRI lab solution for Philips 1.5T MR. This marks an expansion of their long-standing collaboration, enhancing capabilities in MRI-compatible products for interventional procedures. The new solution is the first of its kind available commercially, showcasing innovation in healthcare technology.
Read more →PHGPhilips et Imricor lancent une solution de laboratoire d'IRM interventionnelle cardiaque, renforçant ainsi leur collaboration de longue date
Royal Philips and Imricor Medical Systems have launched a new interventional MRI lab solution for Philips' 1.5 T MRI system. This product marks a significant advancement in their long-standing collaboration, aimed at enhancing cardiac procedures. The new solution is expected to improve the efficiency and effectiveness of interventional MRI applications.
Read more →PHGSamenvatting: Philips en Imricor lanceren een MR-laboratoriumoplossing voor hartingrepen en breiden daarmee hun langdurige samenwerking uit
Royal Philips and Imricor Medical Systems have announced a new interventional MRI laboratory solution for Philips' 1.5T MRI scanners. This launch marks the first commercially available configuration of its kind, enhancing their long-term collaboration. The partnership aims to improve healthcare technology in interventional procedures.
Read more →PHGPhilips and Imricor Launch Cardiac Interventional MR Lab Solution, Expanding Longstanding Collaboration
Philips and Imricor have announced the launch of a new Interventional MR lab solution, integrating Philips' 1.5T MRI platform with Imricor's iMR systems. This collaboration aims to enhance MR-guided workflows for cardiac procedures. The solution is designed to improve efficiency and effectiveness in interventional MR procedures.
Read more →PHGPhilips Avent introduces new automated SMS-based tool to help moms activate their village during postpartum
Philips Avent has launched the Share the Care Connector, an SMS-based tool aimed at helping new mothers organize support from their community during the postpartum period. The initiative, developed in partnership with March of Dimes, addresses the challenges new moms face in asking for help. The tool allows mothers to invite supporters, customize their needs, and receive actionable support suggestions, thereby reducing the emotional burden of coordination.
Read more →PHGAI Moves from Promise to Practice, Transforming Clinical Care Across the U.S., Philips Report Finds
A recent report by Philips indicates that artificial intelligence (AI) is transitioning from theoretical promise to practical application in clinical care across the United States. The findings suggest significant advancements in healthcare technology, showcasing the transformative potential of AI in improving patient outcomes and operational efficiency.
Read more →PHGPhilips receives FDA 510(k) clearance for Elevate Plus for EPIQ Elite and Affiniti, delivering AI advancements in general imaging ultrasound
Philips has received FDA 510(k) clearance for its Elevate Plus system, which enhances the EPIQ Elite and Affiniti ultrasound platforms with AI-driven automation. This technology aims to improve imaging quality, reduce scanning time, and support clinicians in delivering consistent care. The system integrates advanced features like Koios AI for rapid lesion classification and modular upgrades for long-term value.
Read more →PHGPhilips announces exchange ratio for 2025 dividend
Philips has announced an exchange ratio of 1 new common share for every 26.9341 existing shares for its 2025 dividend, calculated based on recent trading prices. Shareholders can choose between receiving dividends in shares or cash, with 43.8% opting for cash. The total number of new shares to be issued is approximately 19.96 million.
Read more →PHGPhilips Lumea IPL 9000 Series and Philips Sonicare 6400 Electric Toothbrush Selected as Good Housekeeping 2026 Beauty Awards Winners
Philips has announced that its Lumea IPL 9000 Series and Sonicare 6400 Electric Toothbrush have been awarded the Good Housekeeping 2026 Beauty Awards. This recognition highlights the effectiveness and innovation of these products in the beauty and dental care sectors.
Read more →PHGPhilips to deliver vital technology for hospital-at-home care for up to 15,000 patients annually in Region Stockholm
Philips, in collaboration with Cuviva and Vingmed, has been awarded a contract to implement a hospital-at-home initiative in Region Stockholm. This program will enable remote monitoring for complex patients, allowing them to receive hospital-level care at home. The initiative aims to improve patient outcomes while addressing healthcare system pressures and is set to serve over 2 million residents.
Read more →PHGPhilips delivers strong order intake, comparable sales growth and margin expansion in Q1; 2026 outlook reiterated
Philips reported a strong start to 2026 with a 6% increase in comparable order intake and a 4% rise in group sales, totaling EUR 3.9 billion. The adjusted EBITA margin improved to 9.0%, driven by higher sales despite challenges from tariffs and cost inflation. The company reiterated its full-year outlook, projecting sales growth of 3%-4.5% and a focus on strategic innovations in health technology.
Read more →PHGFDA clears Philips AI solution that provides real-time guidance during complex minimally invasive heart valve repair
Philips has received FDA 510(k) clearance for its AI-powered DeviceGuide, designed to assist in minimally invasive mitral valve repairs. This software integrates with the Azurion platform, providing real-time imaging and navigation support to enhance procedural accuracy. Developed in collaboration with Edwards Lifesciences, DeviceGuide aims to streamline complex cardiac interventions and improve patient outcomes.
Read more →PHGPhilips launches IntraSight Plus to simplify coronary interventions and advance precision care
Philips has launched IntraSight Plus, an interventional guidance platform cleared for use in the USA and Europe. This platform combines diagnostic and treatment planning tools to enhance workflow efficiency in coronary procedures. It aims to simplify complex interventions and improve patient outcomes by integrating various imaging and assessment technologies into one system.
Read more →PHGPhilips remains No. 1 in Medtech at European Patent Office and the largest Dutch patent applicant
Philips has been recognized as the leading medical technology company by the European Patent Office, filing 1,289 patent applications in 2025. The company focuses on integrating hardware, software, and AI to enhance healthcare solutions. Philips aims to improve the lives of 2.5 billion people annually by 2030, emphasizing innovation in underserved communities.
Read more →PHGPhilips Sonicare declares World Oral Health Night, spotlighting what manual brushing leaves behind
Philips Sonicare is declaring World Oral Health Night on March 20th to highlight the inadequacies of manual brushing in removing plaque. The initiative includes a public installation in New York City that showcases the hidden effects of bacteria growth during the night. Sonicare's technology is designed to enhance oral health by removing significantly more plaque than manual brushing, thereby promoting overall wellness.
Read more →PHGPhilips unveils Rembra CT at ECR 2026, setting a new benchmark for speed and patient access designed to support diagnostic confidence for acute and high-demand imaging environments
Philips has launched Rembra, a next-generation CT system, at ECR 2026, designed to enhance diagnostic speed and patient access in acute imaging environments. With advanced image reconstruction technology, Rembra can produce up to 106 images per second and handle 270 patients daily. Its 85 cm bore accommodates complex cases, improving patient comfort and reducing rescans. The system integrates AI to streamline workflows and enhance diagnostic confidence.
Read more →PHGSHERPA research consortium initiates seven clinical studies to validate AI-based assistive technologies for minimally invasive brain and cancer treatments
The SHERPA research consortium, led by Philips, has launched seven clinical studies aimed at validating AI-assisted technologies for minimally invasive treatments of brain aneurysms and liver tumors. With a budget of EUR 21.5 million, the project seeks to address staffing shortages and improve workflow efficiency in interventional radiology. The studies will be conducted across multiple prestigious medical centers in Europe.
Read more →About Koninklijke Philips N.V. NY Registry Shares
BIOPHARMAWATCH ELITE PLUS
Trade the next PHG catalyst before the market reprices
Every FDA decision, PoA score, 13F move and dilution flag on this page, for 1,100+ biotech tickers. From $19/mo billed annually.
Cancel anytime